AUSTRALIAN Securities Exchange (ASX) listed pharmacy software provider, Corum Group, has announced the appointment of former Ignite Limited CEO, Julian Sallabank, to its board.
Sallabank is currently the Managing Director of a privately owned early stage medical research impact and innovation fund, which collaborates with the Murdoch Children's Research Institute, and has developed a portfolio including therapeutics, diagnostics and digital health.
In a statement to the ASX, Corum said that Sallabank would bring significant experience in strategic planning, commercialisation and organisational development to the board, from both a domestic and international perspective.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Apr 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Apr 20
